{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:23:33Z","timestamp":1777901013357,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T00:00:00Z","timestamp":1274313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s13277-010-0049-1","type":"journal-article","created":{"date-parts":[[2010,5,19]],"date-time":"2010-05-19T09:11:09Z","timestamp":1274260269000},"page":"411-415","source":"Crossref","is-referenced-by-count":49,"title":["Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women"],"prefix":"10.1007","volume":"31","author":[{"given":"Emanuela","family":"Anastasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Granato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia Giovanna","family":"Marchei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Viggiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Colaprisca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Comploj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Gabriella","family":"Reale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Frati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Midulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,20]]},"reference":[{"key":"49_CR1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.bjc.6605462","volume":"102","author":"S Mallett","year":"2010","unstructured":"Mallett S, Timmer A, Sauerbrei W, Altaman DG. Reporting of prognostic studies of tumor markers: a review of articles in relation to REMARK guidelines. Br J Cancer. 2010;102:173\u201380.","journal-title":"Br J Cancer"},{"key":"49_CR2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/17530050903266830","volume":"3","author":"DL Meany","year":"2009","unstructured":"Meany DL, Sokoll LJ, Chan DW. Early detection of cancer: immunoassay for plasma tumor markers. Expert Opin Med Diagn. 2009;3:597\u2013605.","journal-title":"Expert Opin Med Diagn"},{"key":"49_CR3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/clpt.2008.231","volume":"85","author":"RH Glassman","year":"2009","unstructured":"Glassman RH, Ratain MJ. Biomarkers in early cancer drug development: limited utility. Pharmacol Ther. 2009;85:134\u20135.","journal-title":"Pharmacol Ther"},{"key":"49_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/pme.09.49","volume":"7","author":"R Simon","year":"2010","unstructured":"Simon R. Clinical trial for evaluating the medical utility of prognostic and predictive biomarkers in oncology. Per Med. 2010;7:33\u201347.","journal-title":"Per Med"},{"key":"49_CR5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/humrep\/14.2.566","volume":"14","author":"GS Bon","year":"1999","unstructured":"Bon GS, Kenemans P, Dekker JJ, Hompes PG, Verstraeten RA, van Kamp GJ, et al. Fluctuations in CA125 and Ca15-3 serum concentrations during spontaneous ovulatory cycles. Hum Reprod. 1999;14:566\u201370.","journal-title":"Hum Reprod"},{"key":"49_CR6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00404-006-0242-z","volume":"275","author":"H Kafali","year":"2007","unstructured":"Kafali H, Artunc H, Herdem M. Evaluation of factors that may be responsible for cyclic change of CA125 levels during menstrual cycle. Arch Gynecol Obstet. 2007;275:175\u20137.","journal-title":"Arch Gynecol Obstet"},{"key":"49_CR7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1530\/ror.0.0030086","volume":"3","author":"C Kirchhoff","year":"1998","unstructured":"Kirchhoff C. Molecular characterization of epididymal proteins. Rev Reprod. 1998;3:86\u201395.","journal-title":"Rev Reprod"},{"key":"49_CR8","first-page":"2768","volume":"21","author":"L Bingle","year":"2002","unstructured":"Bingle L, Singleton V, Bingle CD. The putative ovarian tumor marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein is forms. Ontogeny. 2002;21:2768\u201373.","journal-title":"Ontogeny"},{"key":"49_CR9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbrc.2005.05.125","volume":"333","author":"A Claus","year":"2005","unstructured":"Claus A, Lila H, Lund wall A. The evolution of a genetic locus encoding small serine proteins inhibitors. Brioche Biophysics Res Common. 2005;333:383\u20139.","journal-title":"Brioche Biophysics Res Common"},{"key":"49_CR10","first-page":"233","volume":"368","author":"A Claus","year":"2002","unstructured":"Claus A, Lila H, Lund wall A. A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acid protein. Brioche J. 2002;368:233\u201342.","journal-title":"Brioche J"},{"key":"49_CR11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-0-387-68969-2_2","volume":"622","author":"I Hellerstrom","year":"2008","unstructured":"Hellerstrom I, Hellertown KE. SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and\/or each other. Adv Exp Med Biol. 2008;622:15\u201321.","journal-title":"Adv Exp Med Biol"},{"key":"49_CR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13277-009-0015-y","volume":"31","author":"E Anastasi","year":"2010","unstructured":"Anastasi E, Marchei GG, Viggiani V, Gennarini G, Frati L, Reale MG. HE4: a new potential early biomarker for the recurrence of ovarian cancer. Tumor Biol. 2010;31:113\u20139.","journal-title":"Tumor Biol"},{"key":"49_CR13","first-page":"23","volume":"72","author":"DX Chen","year":"1988","unstructured":"Chen DX, Schwartz PE, Li XG, Yang Z. Evaluation of CA125 levels in differentiating malignant from benign tumors in patients with pelvic mass. Obstet Gynecol. 1988;72:23\u20137.","journal-title":"Obstet Gynecol"},{"key":"49_CR14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejogrb.2008.08.011","volume":"142","author":"LR Medeiros","year":"2009","unstructured":"Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC. Accuracy of CA125 in the diagnosis of ovarian tumors: a quantitative systematic review. Eur J Obstet Gynecol Reprod Biol. 2009;142:99\u2013105.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"49_CR15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/cncr.24152","volume":"115","author":"C Tian","year":"2009","unstructured":"Tian C, Markman M, Zaino R, Ozols RF, McGuire WP, Muggia FM, et al. CA125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study. Cancer. 2009;115:1395\u2013403.","journal-title":"Cancer"},{"key":"49_CR16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0889-8588(03)00063-7","volume":"17","author":"N Urban","year":"2003","unstructured":"Urban N, McIntosh AM, Karlan B. Ovarian cancer screening. Hematol Oncol Clin North Am. 2003;17:989\u20131005.","journal-title":"Hematol Oncol Clin North Am"},{"key":"49_CR17","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1200\/JCO.2002.20.5.1161","volume":"20","author":"RF Ozols","year":"2002","unstructured":"Ozols RF. Recurrent ovarian cancer: evidence-based treatment. J Clin Oncol. 2002;20:1161\u20133.","journal-title":"J Clin Oncol"},{"key":"49_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/carcin\/bgp269","volume":"31","author":"P Boffetta","year":"2009","unstructured":"Boffetta P. Biomarkers in cancer epidemiology an integrative approach. Carcinogenesis. 2009;31:121\u20136.","journal-title":"Carcinogenesis"},{"key":"49_CR19","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/sj.bjc.6604999","volume":"100","author":"RD Riley","year":"2009","unstructured":"Riley RD, Saurbrei W, Altman DG. Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis and beyond. Br J Cancer. 2009;100:1219\u201329.","journal-title":"Br J Cancer"},{"key":"49_CR20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/j.seminoncol.2009.09.004","volume":"36","author":"D Planchard","year":"2009","unstructured":"Planchard D, Loriot Y, Goubar A, Commo SJC. Differential expression of biomarkers in men and women. Semin Oncol. 2009;36:553\u201365.","journal-title":"Semin Oncol"},{"key":"49_CR21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2004.02.039","volume":"116","author":"H Kafali","year":"2004","unstructured":"Kafali H, Artuc H, Demir N. Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary study. Eur J Obstet Gynecol Reprod Bio. 2004;116:85\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Bio"},{"key":"49_CR22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1155\/1999\/960934","volume":"15","author":"AB Erbagci","year":"1999","unstructured":"Erbagci AB, Ylmaz N, Kutlar I. Menstrual cycle dependent variability for serum tumor markers CEA, AFP, CA 19-9, CA125 and CA15-3 in healthy women. Dis Markers. 1999;15:259\u201367.","journal-title":"Dis Markers"},{"key":"49_CR23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0015-0282(16)53753-4","volume":"54","author":"A Zweers","year":"1990","unstructured":"Zweers A, de Boever J, Serreyn R, Vandekerckhove D. Correlation between peripheral CA125 and ovarian activity. Fertil Steril. 1990;54:490\u20134.","journal-title":"Fertil Steril"},{"key":"49_CR24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00404-006-0242-z","volume":"275","author":"H Kafali","year":"2007","unstructured":"Kafali H, Artunc H, Erdem M. Evaluation of factors that may be responsible for cyclic change of CA125 levels during menstrual cycle. Arch Gynecol Obstet. 2007;275:175\u20137.","journal-title":"Arch Gynecol Obstet"},{"key":"49_CR25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MCP.0b013e32832b98eb","volume":"15","author":"J Creaney","year":"2009","unstructured":"Creaney J, Robinson BW. Serum and pleural fluid biomarkers for mesothelioma. Curr Opin Pulm Med. 2009;15:366\u201370.","journal-title":"Curr Opin Pulm Med"},{"key":"49_CR26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0015-0282(16)55923-8","volume":"59","author":"AG Zeimet","year":"1993","unstructured":"Zeimet AG, Muller-Holzner E, Marth C, Daxenbichler G, Dapunt O. Tumor marker CA125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle. Fertil Steril. 1993;59:1028\u201335.","journal-title":"Fertil Steril"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-010-0049-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-010-0049-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-010-0049-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:24:32Z","timestamp":1559489072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-010-0049-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,20]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1007\/s13277-010-0049-1","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,20]]}}}